Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Psyence Biomedical Ltd. (PBM) vs TScan Therapeutics, Inc. (TCRX)

Psyence Biomedical Ltd. and TScan Therapeutics, Inc. are both Biotechnology companies. Psyence Biomedical Ltd. and TScan Therapeutics, Inc. are of similar size ($23.7M and $22.4M). TScan Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.2×. Psyence Biomedical Ltd. has the higher net margin (0.00% vs −1,655.4%) and the higher return on invested capital (0.00% vs −4,588.2%). Across the 13 metrics below, Psyence Biomedical Ltd. leads on 9 and TScan Therapeutics, Inc. on 4.

Valuation

Metric PBM TCRX Biotechnology median
P/E 0.25 n/m 7.88
P/S n/m 6.21 11.47
P/B 0.11 0.64 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 1.73 0.20 0.74
EV/Sales n/m (3.26) 10.73
Earnings yield 405.89% (267.65%) (28.84%)
Free cash flow yield (613.04%) (268.00%) (23.03%)

Profitability

Metric PBM TCRX Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin — (1,695.15%) 0.00%
Net margin 0.00% (1,655.35%) 0.00%
Free cash flow margin 0.00% (1,665.18%) 0.00%
Return on equity (23.52%) (95.80%) (57.72%)
Return on assets (15.37%) (50.09%) (49.22%)
Return on invested capital 0.00% (4,588.23%) 0.00%

Growth

Metric PBM TCRX Biotechnology median
Revenue growth (TTM) — 2.15% 5.64%
EPS growth (last fiscal year) (138.35%) 12.28% —
Revenue growth, 5-year CAGR — 56.92% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PBM TCRX Biotechnology median
Debt to equity 0.00 0.47 0.00
Current ratio 8.09 3.37 4.73
Net debt to EBITDA 1.20 0.90 0.96

Dividend

Metric PBM TCRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PBM TCRX Biotechnology median
Market cap 22.35m 23.65m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack